NeuroMetrix Performance
| NURODelisted Stock | USD 4.58 0.22 5.05% |
The company secures a Beta (Market Risk) of 0.0269, which conveys not very significant fluctuations relative to the market. As returns on the market increase, NeuroMetrix's returns are expected to increase less than the market. However, during the bear market, the loss of holding NeuroMetrix is expected to be smaller as well. NeuroMetrix right now secures a risk of 0.0%. Please verify NeuroMetrix semi variance, as well as the relationship between the rate of daily change and relative strength index , to decide if NeuroMetrix will be following its current price movements.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days NeuroMetrix has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, NeuroMetrix is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
NeuroMetrix |
NeuroMetrix Relative Risk vs. Return Landscape
If you would invest 458.00 in NeuroMetrix on November 5, 2025 and sell it today you would earn a total of 0.00 from holding NeuroMetrix or generate 0.0% return on investment over 90 days. NeuroMetrix is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than NeuroMetrix, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
NeuroMetrix Target Price Odds to finish over Current Price
The tendency of NeuroMetrix Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 4.58 | 90 days | 4.58 | near 1 |
Based on a normal probability distribution, the odds of NeuroMetrix to move above the current price in 90 days from now is near 1 (This NeuroMetrix probability density function shows the probability of NeuroMetrix Stock to fall within a particular range of prices over 90 days) .
NeuroMetrix Price Density |
| Price |
Predictive Modules for NeuroMetrix
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as NeuroMetrix. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.NeuroMetrix Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. NeuroMetrix is not an exception. The market had few large corrections towards the NeuroMetrix's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold NeuroMetrix, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of NeuroMetrix within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.13 | |
β | Beta against Dow Jones | 0.03 | |
σ | Overall volatility | 0.07 | |
Ir | Information ratio | 0.07 |
NeuroMetrix Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of NeuroMetrix for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for NeuroMetrix can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| NeuroMetrix is not yet fully synchronised with the market data | |
| NeuroMetrix has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 3.03 M. Net Loss for the year was (7.81 M) with profit before overhead, payroll, taxes, and interest of 1.71 M. | |
| NeuroMetrix currently holds about 20.83 M in cash with (7.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.68. | |
| Roughly 15.0% of the company outstanding shares are owned by corporate insiders |
NeuroMetrix Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of NeuroMetrix Stock often depends not only on the future outlook of the current and potential NeuroMetrix's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. NeuroMetrix's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2 M | |
| Cash And Short Term Investments | 13.1 M |
NeuroMetrix Fundamentals Growth
NeuroMetrix Stock prices reflect investors' perceptions of the future prospects and financial health of NeuroMetrix, and NeuroMetrix fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NeuroMetrix Stock performance.
| Return On Equity | -0.45 | |||
| Return On Asset | -0.28 | |||
| Profit Margin | (2.57) % | |||
| Operating Margin | (3.36) % | |||
| Current Valuation | (3.55 M) | |||
| Shares Outstanding | 2.06 M | |||
| Price To Earning | 6.51 X | |||
| Price To Book | 0.66 X | |||
| Price To Sales | 3.11 X | |||
| Revenue | 3.03 M | |||
| EBITDA | (8.78 M) | |||
| Cash And Equivalents | 20.83 M | |||
| Cash Per Share | 2.68 X | |||
| Total Debt | 107.35 K | |||
| Debt To Equity | 0.02 % | |||
| Book Value Per Share | 6.98 X | |||
| Cash Flow From Operations | (7.13 M) | |||
| Earnings Per Share | (3.96) X | |||
| Total Asset | 15.32 M | |||
| Retained Earnings | (217.92 M) | |||
| Current Asset | 10.59 M | |||
| Current Liabilities | 3.59 M | |||
About NeuroMetrix Performance
By examining NeuroMetrix's fundamental ratios, stakeholders can obtain critical insights into NeuroMetrix's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that NeuroMetrix is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts. Neurometrix operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 23 people.Things to note about NeuroMetrix performance evaluation
Checking the ongoing alerts about NeuroMetrix for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for NeuroMetrix help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NeuroMetrix is not yet fully synchronised with the market data | |
| NeuroMetrix has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 3.03 M. Net Loss for the year was (7.81 M) with profit before overhead, payroll, taxes, and interest of 1.71 M. | |
| NeuroMetrix currently holds about 20.83 M in cash with (7.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.68. | |
| Roughly 15.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing NeuroMetrix's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NeuroMetrix's stock is overvalued or undervalued compared to its peers.
- Examining NeuroMetrix's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NeuroMetrix's management team can have a significant impact on its success or failure. Reviewing the track record and experience of NeuroMetrix's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NeuroMetrix's stock. These opinions can provide insight into NeuroMetrix's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in poverty. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in NeuroMetrix Stock
If you are still planning to invest in NeuroMetrix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NeuroMetrix's history and understand the potential risks before investing.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |